title: Alcohol-preferring P rats emit spontaneous 22-28 kHz ultrasonic vocalizations that are altered by acute and chronic alcohol experience.
abstract: BACKGROUND
  Emotional states are often thought to drive excessive alcohol intake and influence the development of alcohol use disorders. To gain insight into affective properties associated with excessive alcohol intake, we utilized ultrasonic vocalization (USV) detection and analyses to characterize the emotional phenotype of selectively bred alcohol-preferring (P) rats; an established animal model of excessive alcohol intake. USVs emitted by rodents have been convincingly associated with positive (50-55 kHz frequency-modulated [FM]) and negative (22-28 kHz) affective states. Therefore, we hypothesized that 50-55 and 22-28 kHz USV emission patterns in P rats would reveal a unique emotional phenotype sensitive to alcohol experience.
  
  
  METHODS
  50-55 kHz FM and 22-28 kHz USVs elicited from male P rats were assessed during access to water, 15 and 30% EtOH (v/v). Ethanol (EtOH; n = 12) or water only (Control; n = 4) across 8 weeks of daily drinking-in-the-dark (DID) sessions.
  
  
  RESULTS
  Spontaneous 22-28 kHz USVs are emitted by alcohol-naïve P rats and are enhanced by alcohol experience. During DID sessions when alcohol was not available (e.g., "EtOH OFF" intervals), significantly more 22-28 kHz than 50-55 kHz USVs were elicited, while significantly more 50-55 kHz FM than 22-28 kHz USVs were emitted when alcohol was available (e.g., "EtOH ON" intervals). In addition, USV acoustic property analyses revealed chronic effects of alcohol experience on 22-28 kHz USV mean frequency, indicative of lasting alcohol-mediated alterations to neural substrates underlying emotional response.
  
  
  CONCLUSIONS
  Our findings demonstrate that acute and chronic effects of alcohol exposure are reflected in changes in 22-28 and 50-55 kHz FM USV counts and acoustic patterns. These data support the notion that initiation and maintenance of alcohol intake in P rats may be due to a unique, alcohol-responsive emotional phenotype and further suggest that spontaneous 22-28 kHz USVs serve as behavioral markers for excessive drinking vulnerability.
authors.affiliation: Department of Psychology, The University of Texas at Austin, Austin, Texas; Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, Texas.
authors.forename: James M
authors.initials: JM
authors.lastname: Reno
authors.forename: Neha
authors.initials: N
authors.lastname: Thakore
authors.forename: Rueben
authors.initials: R
authors.lastname: Gonzales
authors.forename: Timothy
authors.initials: T
authors.lastname: Schallert
authors.forename: Richard L
authors.initials: RL
authors.lastname: Bell
authors.forename: W Todd
authors.initials: WT
authors.lastname: Maddox
authors.forename: Christine L
authors.initials: CL
authors.lastname: Duvauchelle
mesh_terms: D000818:Animals; D000431:Ethanol / Q000008:administration & dosage* / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012646:Self Administration; D014828:Vocalization, Animal / Q000187:drug effects*
chemical_list: D000431:Ethanol
keywords: Drinking-In-The-Dark; Emotional Status; Excessive Alcohol Intake; Negative Affect; WAAVES
references.citation: J Stud Alcohol. 2000 Sep;61(5):647-51
references.pmid: 11022801
references.citation: Brain Res Bull. 2003 May 15;60(3):263-74
references.pmid: 12754088
references.citation: Neuroscience. 2003;120(4):1149-56
references.pmid: 12927219
references.citation: Brain Res. 2003 Oct 3;986(1-2):22-9
references.pmid: 12965226
references.citation: J Neurosci. 2004 Feb 4;24(5):1050-7
references.pmid: 14762123
references.citation: Alcohol Clin Exp Res. 2004 Apr;28(4):535-43
references.pmid: 15100603
references.citation: Pharmacol Biochem Behav. 1982 Jan;16(1):145-9
references.pmid: 6173885
references.citation: Pharmacol Biochem Behav. 1987 Feb;26(2):389-92
references.pmid: 2437596
references.citation: Behav Brain Res. 1994 Aug 31;63(2):133-43
references.pmid: 7999296
references.citation: Alcohol. 1995 Sep-Oct;12(5):403-12
references.pmid: 8519434
references.citation: J Neurosci Methods. 1995 Nov;62(1-2):1-5
references.pmid: 8750078
references.citation: Alcohol Clin Exp Res. 1997 Oct;21(7):1232-40
references.pmid: 9347084
references.citation: Pharmacol Biochem Behav. 2004 Nov;79(3):439-50
references.pmid: 15582015
references.citation: Neuropsychopharmacology. 2005 Feb;30(2):330-8
references.pmid: 15383830
references.citation: Alcohol Alcohol. 2005 Sep-Oct;40(5):349-58
references.pmid: 16043436
references.citation: J Comp Neurol. 2005 Nov 7;492(1):34-49
references.pmid: 16175554
references.citation: Psychopharmacology (Berl). 2005 Oct;181(4):714-21
references.pmid: 15983797
references.citation: Neurosci Biobehav Rev. 2005;29(8):1169-80
references.pmid: 16085313
references.citation: J Pharmacol Exp Ther. 2005 Nov;315(2):648-57
references.pmid: 16076936
references.citation: Behav Brain Res. 2006 Mar 15;168(1):64-73
references.pmid: 16343652
references.citation: Alcohol Clin Exp Res. 2006 Aug;30(8):1322-35
references.pmid: 16899035
references.citation: Addict Biol. 2006 Sep;11(3-4):270-88
references.pmid: 16961759
references.citation: Biochem Pharmacol. 2006 Oct 16;72(8):919-27
references.pmid: 16764827
references.citation: Neurosci Biobehav Rev. 2011 Oct;35(9):1831-6
references.pmid: 21144859
references.citation: Pharmacol Biochem Behav. 2011 Nov;100(1):90-7
references.pmid: 21824488
references.citation: Alcohol. 2014 May;48(3):209-15
references.pmid: 24268381
references.citation: Alcohol. 2014 May;48(3):225-34
references.pmid: 24290311
references.citation: Behav Brain Res. 2007 Sep 4;182(2):166-72
references.pmid: 17173984
references.citation: Behav Brain Res. 2007 Sep 4;182(2):274-83
references.pmid: 17449117
references.citation: Physiol Behav. 2008 Mar 18;93(4-5):766-76
references.pmid: 18191963
references.citation: Physiol Behav. 2008 Jun 9;94(3):374-83
references.pmid: 18328511
references.citation: J Comp Psychol. 2008 Nov;122(4):357-67
references.pmid: 19014259
references.citation: Behav Brain Res. 2009 Jan 30;197(1):205-9
references.pmid: 18809437
references.citation: ILAR J. 2009;50(1):43-50
references.pmid: 19106451
references.citation: Behav Brain Res. 2010 Sep 1;212(1):109-14
references.pmid: 20382187
references.citation: Pharmacol Biochem Behav. 2010 Sep;96(3):251-9
references.pmid: 20493210
references.citation: Behav Brain Res. 2010 Dec 6;214(1):75-9
references.pmid: 20470830
references.citation: J Neurosci. 2011 Apr 6;31(14):5205-12
references.pmid: 21471355
references.citation: Am J Primatol. 2011 Jun;73(6):545-61
references.pmid: 21319205
references.citation: Psychopharmacology (Berl). 2012 Feb;219(4):1141-52
references.pmid: 21870038
references.citation: Psychopharmacology (Berl). 2012 Sep;223(1):75-88
references.pmid: 22461104
references.citation: Neurobiol Learn Mem. 2012 Sep;98(2):154-64
references.pmid: 22677211
references.citation: Stress. 2012 Sep;15(5):533-44
references.pmid: 22150360
references.citation: Pharmacol Biochem Behav. 2012 Nov;103(1):119-55
references.pmid: 22841890
references.citation: Neuropsychopharmacology. 2013 Mar;38(4):647-54
references.pmid: 23212453
references.citation: Addict Behav. 2013 Apr;38(4):1970-9
references.pmid: 23380493
references.citation: Subst Use Misuse. 2013 Mar;48(4):297-308
references.pmid: 23368670
references.citation: Curr Opin Neurobiol. 2013 Jun;23(3):310-7
references.pmid: 23375168
references.citation: Psychopharmacology (Berl). 2013 Aug;228(3):389-400
references.pmid: 23503684
references.citation: J Neurosci Methods. 2013 Sep 30;219(1):155-61
references.pmid: 23832016
references.citation: Psychopharmacology (Berl). 2013 Oct;229(4):687-700
references.pmid: 23700082
references.citation: Cell Tissue Res. 2013 Oct;354(1):81-97
references.pmid: 23576070
references.citation: J Neurosci Methods. 2014 Jan 15;221:230-2
references.pmid: 24091135